You are here:
Home
>
Stocks
>
News&Review
>
Life Sciences
>
Pharmaceutical
Sanjiu Pharma subsidiary to build $44 mln API project in Liaoning
Interfax China--02-20-2009
[
-
]
Text
[
+
]
Gosun Pharmaceutical Co. Ltd., a wholly-owned subsidiary of Sanjiu Medical & Pharmaceutical Co. Ltd., will build a RMB 300 million ($43.89 million) project in Xinmin City, Liaoning Province, to produce and distribute cephalosporin antibiotic active pharmaceutical ingredients (APIs), local media reported on Feb. 20.
Related Reports
More
China Chemical Pharmaceutical Market Report, 2008
China Vaccine Market Report, 2007-2009
China Pharmaceutical Chain Industry Report, 2007-2008
China Chemical Pharmaceutical Industry Report, 2007
Company Study of Guangxi Wuzhou Zhongheng Group
China OTC Drug Market Report, 2007
Home
Industries
Consumer Goods
Textile
Households
Agriculture
Food&Beverage
Manufacturing
Energy
Metals&Minerals
Material
Machinery
Chemical
Automotive
Life Sciences
Biotechnology
Pharmaceutical
Medical
Technology&Media
Hardware
Software
Telecommunications
Cyber Economy
Media
Consumer Electronics
Public Sector
Training
Infrastructure
Environment
Finance Service
Retailing
Real Estate
Logistics
Tourism
Economy
Macro Economy
Trade
Investment
Laws&Regulations
Other
Stocks
News&Review
Announcement
Balance Sheet
Income Statement
Cash Flow Statement
Our Services
Investment
Research
Consulting
Due Dilegence
Projects
Charts
Mailing List
About Us
About InvestToChina
Corporate News
Our Team
Contact Us
2008-2009 www.investtochina.com All Rights Reserved